NovoCure Limited
NVCR
$12.43
$0.524.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.14M | -34.32M | -65.92M | -30.57M | -33.38M |
| Total Depreciation and Amortization | 3.44M | 3.33M | 1.74M | 2.46M | 2.86M |
| Total Amortization of Deferred Charges | -- | -- | 5.14M | -- | -- |
| Total Other Non-Cash Items | 27.40M | 22.84M | 50.99M | 23.36M | 25.42M |
| Change in Net Operating Assets | -6.64M | -27.51M | 4.61M | 15.13M | 3.38M |
| Cash from Operations | -15.94M | -35.67M | -3.45M | 10.38M | -1.72M |
| Capital Expenditure | -5.49M | -10.61M | -8.94M | -10.68M | -11.45M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.47M | 4.14M | -13.27M | 20.88M | -362.99M |
| Cash from Investing | 35.99M | -6.47M | -22.21M | 10.19M | -374.44M |
| Total Debt Issued | -- | -- | 0.00 | -- | 96.92M |
| Total Debt Repaid | -- | -- | 0.00 | -- | -12.91M |
| Issuance of Common Stock | 2.39M | 5.25M | 2.69M | 100.00K | 3.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.39M | 5.25M | 2.69M | 100.00K | 87.32M |
| Foreign Exchange rate Adjustments | 265.00K | 227.00K | -128.00K | 87.00K | -77.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.70M | -36.66M | -23.11M | 20.76M | -288.92M |